About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc. develops innovative proprietary drugs selected from its extensive portfolio with the potential to be safe and effective for improving patient care. The company’s product pipeline includes new uses for approved drugs and new molecular entities (“NMEs”) for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation, sexual dysfunction and CNS disease. Central to the company’s successful clinical development programs are its strong relationships with clinicians, academic medical centers, regional hospitals and specialized product and service providers. A phase II clinical development program is underway in addition to sponsored basic, translational and clinical research projects aimed at specific disease mechanisms. The company has built a robust portfolio of issued patents and pending patent applications on its products.

website icon
Website
employees icon
Employees
industry icon
Industry
IT Services and IT Consulting
location icon
Phone number
720-437-6500
location icon
Headquarter
Greenwood Village, Colorado
description icon
Founded
2011

Ampio Pharmaceuticals Alternatives

Industry
Therapeutics
Industry
Therapeutics
Industry
Therapeutics
Industry
Therapeutics
Industry
Therapeutics
Industry
Therapeutics
Industry
Therapeutics

Frequently Asked Questions about Ampio Pharmaceuticals

Who are the decision makers in Ampio Pharmaceuticals?

The decision makers in Ampio Pharmaceuticals are Vaughan Clift, etc. Click to Find Ampio Pharmaceuticals decision makers emails.

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.

Discover the source of our data

Learn more